Drug Profile
RDX 8940
Alternative Names: RDX8940Latest Information Update: 08 May 2023
Price :
$50
*
At a glance
- Originator Ardelyx
- Class
- Mechanism of Action GPBAR1 protein agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Non-alcoholic steatohepatitis